Aptevo Therapeutics Inc.APVONASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank64
3Y CAGR-12.6%
5Y CAGR-6.5%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
-12.6%/yr
vs -21.2%/yr prior
5Y CAGR
-6.5%/yr
Recent deceleration
Acceleration
+8.6pp
Accelerating
Percentile
P64
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2024 | 14.81% |
| 2023 | -0.83% |
| 2022 | -33.84% |
| 2021 | 22.16% |
| 2020 | 32.88% |
| 2019 | 20.72% |
| 2018 | 4.23% |
| 2017 | 57.50% |
| 2016 | -107.77% |
| 2015 | -18.66% |